For the quarter ended June 2024, Cardinal Health (CAH) reported revenue of $59.87 billion, up 12% from the same period last year. Earnings per share were $1.84, compared to $1.55 in the year-ago quarter.
Reported revenue represents a surprise of +1.95% versus the Zacks Consensus Estimate of $58.72 billion. Against a consensus estimate of $1.72 per share, the EPS surprise was +6.98%.
While investors closely examine year-over-year revenue and earnings changes versus Wall Street expectations to determine their next moves, some key metrics always provide a more accurate picture of a company’s financial health.
Since these metrics play a crucial role in determining sales and profit figures, investors can better assess the price development of a share by comparing it with previous year figures and analysts’ estimates.
Here’s how Cardinal performed in the just-released quarter in terms of the metrics most watched and forecasted by Wall Street analysts:
-
Revenue in the pharmaceutical segment – sales and services for pharmaceuticals and specialty pharmaceuticals
: $55.61 billion compared to the average estimate of four analysts of $54.67 billion.
-
Income – Other
: $1.17 billion compared to the average estimate of $1.16 billion based on four analysts.
-
Sales in the medical segment – Medical products and distribution
: $3.11 billion versus the average estimate of the four analysts of $3.17 billion. The reported figure represents a change of +0.3% year-over-year.
-
Segment result – Other
: $111 million compared to the average estimate of $118.82 million based on four analysts.
-
Pharma segment result
: $482 million versus the average estimate of four analysts of $488.12 million.
All important company figures for Cardinal can be found here>>>
Cardinal shares have returned +7.5% over the past month versus a change of -3.2% for the Zacks S&P 500 Composite. The stock currently has a Zacks Rank #3 (Hold), suggesting it could perform in line with the broader market in the near future.
Want the latest recommendations from Zacks Investment Research? Download the 7 best stocks for the next 30 days today. Click here to get this free report
Cardinal Health, Inc. (CAH): Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks Investment Research
